Alteronol Enhances the Anti-tumor Activity and Reduces the Toxicity of High-Dose Adriamycin in Breast Cancer

Overview of attention for article published in Frontiers in Pharmacology, March 2019

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 168,294 followers.

RT @_atanas_: Alteronol Enhances the Anti-tumor Activity and Reduces the Toxicity of High-Dose Adriamycin in Breast Cancer https://t.co/3tS…

RT @_atanas_: Alteronol Enhances the Anti-tumor Activity and Reduces the Toxicity of High-Dose Adriamycin in Breast Cancer https://t.co/3tS…

RT @_atanas_: Alteronol Enhances the Anti-tumor Activity and Reduces the Toxicity of High-Dose Adriamycin in Breast Cancer https://t.co/3tS…

Alteronol Enhances the Anti-tumor Activity and Reduces the Toxicity of High-Dose Adriamycin in Breast Cancer https://t.co/3tS4rNmgSy

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.